Canada Life’s IDEAYA Biosciences IDYA Stock Holding History

Canada Life’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255K	Hold	7,636	–	–	﹤0.01%	1572
2025 Q4	$264K	Sell	7,636 -9,780	-56%	-$312K	﹤0.01%	1595
2025 Q3	$474K	Hold	17,416	–	–	﹤0.01%	1611
2025 Q2	$367K	Buy	17,416 +1,609	+10%	+$30.9K	﹤0.01%	1652
2025 Q1	$259K	Hold	15,807	–	–	﹤0.01%	1702
2024 Q4	$406K	Hold	15,807	–	–	﹤0.01%	1673
2024 Q3	$501K	Hold	15,807	–	–	﹤0.01%	1669
2024 Q2	$555K	Buy	15,807 +4,708	+42%	+$186K	﹤0.01%	1662
2024 Q1	$487K	Buy	11,099 +6,069	+121%	+$261K	﹤0.01%	1694
2023 Q4	$178K	Hold	5,030	–	–	﹤0.01%	1857
2023 Q3	$136K	Buy	5,030 +2,973	+145%	+$75.4K	﹤0.01%	1914
2023 Q2	$49K	Hold	2,057	–	–	﹤0.01%	2009
2023 Q1	$28K	Hold	2,057	–	–	﹤0.01%	2156
2022 Q4	$38K	Buy	2,057 +1,036	+101%	+$17.4K	﹤0.01%	2134
2022 Q3	$15K	Hold	1,021	–	–	﹤0.01%	2299
2022 Q2	$14K	Hold	1,021	–	–	﹤0.01%	2325
2022 Q1	$12K	Hold	1,021	–	–	﹤0.01%	2413
2021 Q4	$24K	Buy	+1,021	New	+$23.7K	﹤0.01%	2340

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Canada Life's IDYA Position: Q1 2026 in Review

Canada Life held its IDEAYA Biosciences (IDYA) position steady in Q1 2026 at 7,636 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1572.

Canada Life first reported a position in IDYA in Q4 2021 and has held it in 18 quarters since. The position peaked at $555K in Q2 2024. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

Canada Life held 7,636 shares of IDEAYA Biosciences worth $255K as of Q1 2026.
Canada Life left its IDEAYA Biosciences share count unchanged in Q1 2026.
IDEAYA Biosciences made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1572 holding.
Canada Life first reported a position in IDEAYA Biosciences in Q4 2021 and has held it in 18 quarters since.
Canada Life's IDEAYA Biosciences position peaked at $555K in Q2 2024.
253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.